CHDR Annual Report 2024
Contents 2024
  • Homepage
  • 2024 in perspective
  • Developing drugs
  • Developing methods
  • Developing people
  • 2024 stories
Other years

2024 stories

CHDR strives to create value for patients, professionals and the wider population, both leading and responding to new developments in the field. Read about how we adapted to change and launched novel projects in 2024.

Collaborating on behalf of cancer patients

Immunodermatology consortium at the start of a nationwide observational study

‘It is important that patients are involved in the NGID consortium’

New CHDR Unit in the Eastern Netherlands to Expand Research Capacity

New CFO Anouk de Jong: ‘Strategic thinking is the common thread in my career’

Using study participants' feedback to improve recruitment

Culture programme in implementation phase

Feedback-driven HR: strengthening CHDR’s workforce

CHDR plays key role in national infectious diseases facility

Marieke Niesters appointed as head of the Pain group

Back to homepage
  • © CHDR 2026
  • +31 (0)71 5246400
  • info@chdr.nl
  • www.chdr.nl